Abstract
Yeast, fungal, and mammalian prions determine heritable as well as infectious traits. In mammals, prions cause a group of fatal and rapidly progressive neurodegenerative diseases, originally described as transmissible spongiform encephalopathies (TSEs). Variations in prions, which cause different disease phenotypes, are referred to as strains. Mammalian prion strains are differentiated by qualitative characteristics such as clinical symptoms, brain pathology, targeted brain anatomical areas and cells, or Western blot patterns of glycosylated or deglycosylated pathogenic prion protein (PrPSc). Quantitative prion traits are determined by incubation time, prion dose response, proteolytic sensitivity, and conformational stability of PrPSc. The high degree of fidelity with which prion strains replicate requires a precise molecular mechanism that can account for all these characteristics. Remarkable progress in the past decade produced many lines of evidence arguing that prion traits are encoded in the self-replicating conformation of PrPSc that is unique for each strain. Thus, prions behave like proteinaceous genes. The determination of the full spectrum of human and animal prion strains and the conformational features in the pathogenic human prion protein that govern replication of prion strains is essential for the development of diagnostic as well as therapeutic strategies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ALS:
-
Amyotrophic lateral sclerosis
- CDI:
-
Conformation-dependent immunoassay
- CHO:
-
N-linked complex glycosylation chains
- CJD:
-
Creutzfeldt–Jakob disease
- CPA:
-
Cell panel assay
- ER:
-
Endoplasmic reticulum
- FFI:
-
Fatal familial insomnia
- GSS:
-
Gerstmann–Sträussler–Scheinker syndrome
- PMCA:
-
Protein misfolding cyclic amplification
- PRNP:
-
Prion protein gene
- PrP:
-
Prion protein
- PrPC :
-
Normal or cellular prion protein
- PrPSc :
-
Pathogenic prion protein
- rPrPSc :
-
Protease-resistant conformers of pathogenic prion protein (PrP 27-30)
- sCJD:
-
Sporadic Creutzfeldt–Jakob disease
- SFI:
-
Sporadic fatal insomnia
- sPrPSc :
-
Protease-sensitive conformers of pathogenic prion protein
- SSCA:
-
Standard scrapie cell assay
- TSE:
-
Transmissible spongiform encephalopathy
- VPSPr:
-
Variable protease-sensitive prionopathy
- WB:
-
Western blot
References
Anfinsen CB (1973) Principles that govern the folding of protein chains. Science 181:223–230
Barria MA, Mukherjee A, Gonzalez-Romero D, Morales R, Soto C (2009) De novo generation of infectious prions in vitro produces a new disease phenotype. PLoS Pathog 5:e1000421
Bennett MJ, Schlunegger MP, Eisenberg D (1995) 3D domain swapping: a mechanism for oligomer assembly. Protein Sci 4:2455–2468
Bergstrom AL, Jensen TK, Heegaard PM, Cordes H, Hansen VB, Laursen H et al (2006) Short-term study of the uptake of PrP(Sc) by the Peyer’s patches in hamsters after oral exposure to scrapie. J Comp Pathol 134:126–133
Bessen RA, Marsh RF (1992) Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol 66:2096–2101
Bessen RA, Marsh RF (1994) Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68:7859–7868
Bishop MT, Will RG, Manson JC (2010) Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci USA 107:12005–12010
Borchelt DR, Scott M, Taraboulos A, Stahl N, Prusiner SB (1990) Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol 110:743–752
Brown P, Gibbs CJ Jr, Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A et al (1994) Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 35:513–529
Browning SR, Mason GL, Seward T, Green M, Eliason GA, Mathiason C et al (2004) Transmission of prions from mule deer and elk with chronic wasting disease to transgenic mice expressing cervid PrP. J Virol 78:13345–13350
Bruce ME, Dickinson AG (1979) Biological stability of different classes of scrapie agent. In: Prusiner SB, Hadlow WJ (eds) Slow transmissible diseases of the nervous system, vol 2. Academic, New York, pp 71–86
Bruce ME, Dickinson AG (1987) Biological evidence that the scrapie agent has an independent genome. J Gen Virol 68:79–89
Büeler H, Aguzzi A, Sailer A, Greiner R-A, Autenried P, Aguet M et al (1993) Mice devoid of PrP are resistant to scrapie. Cell 73:1339–1347
Cali I, Castellani R, Alshekhlee A, Cohen Y, Blevins J, Yuan J et al (2009) Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain 132:2643–2658
Carlson GA, Ebeling C, Yang S-L, Telling G, Torchia M, Groth D et al (1994a) Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice. Proc Natl Acad Sci USA 91:5690–5694
Carlson GA, DeArmond SJ, Torchia M, Westaway D, Prusiner SB (1994b) Genetics of prion diseases and prion diversity in mice. Philos Trans R Soc Lond B Biol Sci 343:363–369
Castilla J, Saa P, Hetz C, Soto C (2005) In vitro generation of infectious scrapie prions. Cell 121:195–206
Caughey B, Raymond GJ (1991) The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem 266:18217–18223
Caughey B, Raymond GJ, Bessen RA (1998) Strain-dependent differences in b-sheet conformations of abnormal prion protein. J Biol Chem 273:32230–32235
Caughey B, Baron GS, Chesebro B, Jeffrey M (2009) Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu Rev Biochem 78:177–204
Chandler RL (1961) Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet 277:1378–1379
Choi YP, Peden AH, Groner A, Ironside JW, Head MW (2011) Distinct stability states of disease-associated human prion protein identified by conformation-dependent immunoassay. J Virol 84:12030–12038
Cobb NJ, Surewicz WK (2009) Prion diseases and their biochemical mechanisms. Biochemistry 48:2574–2585
Cohen FE, Prusiner SB (1998) Pathologic conformations of prion proteins. Annu Rev Biochem 67:793–819
Colby DW, Wain R, Baskakov IV, Legname G, Palmer CG, Nguyen HO et al (2010) Protease-sensitive synthetic prions. PLoS Pathog 6:e1000736
Collinge J, Clarke AR (2007) A general model of prion strains and their pathogenicity. Science 318:930–936
Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF (1996) Molecular analysis of prion strain variation and the aetiology of “new variant” CJD. Nature 383:685–690
Collinge J, Gorham M, Hudson F, Kennedy A, Keogh G, Pal S et al (2009) Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial. Lancet Neurol 8:334–344
Cronier S, Gros N, Tattum MH, Jackson GS, Clarke AR, Collinge J et al (2008) Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem J 416:297–305
DeArmond SJ, Sánchez H, Yehiely F, Qiu Y, Ninchak-Casey A, Daggett V et al (1997) Selective neuronal targeting in prion disease. Neuron 19:1337–1348
Deleault NR, Geoghegan JC, Nishina K, Kascsak R, Williamson RA, Supattapone S (2005) Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions. J Biol Chem 280:26873–26879
Deleault NR, Harris BT, Rees JR, Supattapone S (2007) Formation of native prions from minimal components in vitro. Proc Natl Acad Sci USA 104:9741–9746
Deleault NR, Kascsak R, Geoghegan JC, Supattapone S (2010) Species-dependent differences in cofactor utilization for formation of the protease-resistant prion protein in vitro. Biochemistry 49(18):3928–3934
Deleault NR, Piro JR, Walsh DJ, Wang F, Ma J, Geoghegan JC et al (2012) Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc Natl Acad Sci USA 109:8546–8551
Dickinson AG, Fraser HG (1977) Scrapie: pathogenesis in inbred mice: an assessment of host control and response involving many strains of agent. In: ter Meulen V, Katz M (eds) Slow virus infections of the central nervous system. Springer, New York, pp 3–14
Dickinson AG, Outram GW (1988) Genetic aspects of unconventional virus infections: the basis of the virino hypothesis. In: Bock G, Marsh J (eds) Novel infectious agents and the central nervous system. CIBA Foundation Symposium 135. Wiley, Chichester, pp 63–83
Dickinson AG, Fraser H, Meikle VMH, Outram GW (1972) Competition between different scrapie agents in mice. Nat New Biol 237:244–245
Endo T, Groth D, Prusiner SB, Kobata A (1989) Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. Biochemistry 28:8380–8388
Fraser H, Dickinson AG (1973) Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation. J Comp Pathol 83:29–40
Gambetti P, Kong Q, Zou W, Parchi P, Chen SG (2003) Sporadic and familial CJD: classification and characterisation. Br Med Bull 66:213–239
Geoghegan JC, Valdes PA, Orem NR, Deleault NR, Williamson RA, Harris BT et al (2007) Selective incorporation of polyanionic molecules into hamster prions. J Biol Chem 282:36341–36353
Geoghegan JC, Miller MB, Kwak AH, Harris BT, Supattapone S (2009) Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor. PLoS Pathog 5:e1000535
Ghaemmaghami S, Phuan PW, Perkins B, Ullman J, May BC, Cohen FE et al (2007) Cell division modulates prion accumulation in cultured cells. Proc Natl Acad Sci USA 104:17971–17976
Gibbs CJ Jr, Gajdusek DC, Asher DM, Alpers MP, Beck E, Daniel PM et al (1968) Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science 161:388–389
Giles K, Glidden DV, Patel S, Korth C, Groth D, Lemus A et al (2010) Human prion strain selection in transgenic mice. Ann Neurol 68:151–161
Head MW, Bunn TJ, Bishop MT, McLoughlin V, Lowrie S, McKimmie CS et al (2004) Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991–2002. Ann Neurol 55:851–859
Hill AF, Desbruslais M, Joiner S, Sidle KCL, Gowland I, Collinge J et al (1997) The same prion strain causes vCJD and BSE. Nature 389:448–450
Jones EM, Surewicz WK (2005) Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids. Cell 121:63–72
Kaneko K, Zulianello L, Scott M, Cooper CM, Wallace AC, James TL et al (1997) Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci USA 94:10069–10074
Karapetyan YE, Saa P, Mahal SP, Sferrazza GF, Sherman A, Sales N et al (2009) Prion strain discrimination based on rapid in vivo amplification and analysis by the cell panel assay. PLoS One 4:e5730
Kellings K, Meyer N, Mirenda C, Prusiner SB, Riesner D (1992) Further analysis of nucleic acids in purified scrapie prion preparations by improved return refocussing gel electrophoresis (RRGE). J Gen Virol 73:1025–1029
Kellings K, Prusiner SB, Riesner D (1994) Nucleic acids in prion preparations: unspecific background or essential component? Philos Trans R Soc Lond B Biol Sci 343:425–430
Kim JI, Cali I, Surewicz K, Kong Q, Raymond GJ, Atarashi R et al (2010) Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J Biol Chem 285:14083–14087
Kim C, Haldiman T, Cohen Y, Chen W, Blevins J, Sy MS et al (2011) Protease-sensitive conformers in broad spectrum of distinct PrP structures in sporadic Creutzfeldt-Jakob disease are indicator of progression rate. PLoS Pathog 7:e1002242
Kimberlin RH, Walker CA (1978) Pathogenesis of mouse scrapie: effect of route of inoculation on infectivity titres and dose–response curves. J Comp Pathol 88:39–47
Kimberlin RH, Cole S, Walker CA (1987) Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters. J Gen Virol 68:1875–1881
King DJ, Safar JG, Legname G, Prusiner SB (2007) Thioaptamer interactions with prion proteins: sequence-specific and non-specific binding sites. J Mol Biol 369:1001–1014
Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT Jr et al (1994) Cell-free formation of protease-resistant prion protein. Nature 370:471–474
Kovacs GG, Head MW, Hegyi I, Bunn TJ, Flicker H, Hainfellner JA et al (2002) Immunohistochemistry for the prion protein: comparison of different monoclonal antibodies in human prion disease subtypes. Brain Pathol 12:1–11
Legname G, Baskakov IV, Nguyen H-OB, Riesner D, Cohen FE, DeArmond SJ et al (2004) Synthetic mammalian prions. Science 305:673–676
Legname G, Nguyen H-OB, Peretz D, Cohen FE, DeArmond SJ, Prusiner SB (2006) Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci USA 103:19105–19110
Lewis V, Hill AF, Klug GM, Boyd A, Masters CL, Collins SJ (2005) Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles. Neurology 65:113–118
Li J, Browning S, Mahal SP, Oelschlegel AM, Weissmann C (2010) Darwinian evolution of prions in cell culture. Science 327:869–872
Mahal SP, Baker CA, Demczyk CA, Smith EW, Julius C, Weissmann C (2007) Prion strain discrimination in cell culture: the cell panel assay. Proc Natl Acad Sci USA 104:20908–20913
Meyer N, Rosenbaum V, Schmidt B, Gilles K, Mirenda C, Groth D et al (1991) Search for a putative scrapie genome in purified prion fractions reveals a paucity of nucleic acids. J Gen Virol 72:37–49
Mishra RS, Basu S, Gu Y, Luo X, Zou WQ, Mishra R et al (2004) Protease-resistant human prion protein and ferritin are cotransported across Caco-2 epithelial cells: implications for species barrier in prion uptake from the intestine. J Neurosci 24:11280–11290
Monari L, Chen SG, Brown P, Parchi P, Petersen RB, Mikol J et al (1994) Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci USA 91:2839–2842
Morales R, Abid K, Soto C (2007) The prion strain phenomenon: molecular basis and unprecedented features. Biochim Biophys Acta 1772:681–691
Paravastu AK, Leapman RD, Yau WM, Tycko R (2008) Molecular structural basis for polymorphism in Alzheimer’s beta-amyloid fibrils. Proc Natl Acad Sci USA 105:18349–18354
Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG et al (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 39:767–778
Parchi P, Capellari S, Chen SG, Petersen RB, Gambetti P, Kopp P et al (1997) Typing prion isoforms. Nature 386:232–233
Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O et al (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224–233
Pattison IH, Millson GC (1961) Scrapie produced experimentally in goats with special reference to the clinical syndrome. J Comp Pathol 71:101–108
Peretz D, Scott M, Groth D, Williamson A, Burton D, Cohen FE et al (2001) Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci 10:854–863
Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, Delaglio F et al (2002) A structural model for Alzheimer’s beta-amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci USA 99:16742–16747
Pirisinu L, Di Bari M, Marcon S, Vaccari G, D’Agostino C, Fazzi P et al (2011) A new method for the characterization of strain-specific conformational stability of protease-sensitive and protease-resistant PrP. PLoS One 5:e12723
Piro JR, Supattapone S (2011) Photodegradation illuminates the role of polyanions in prion infectivity. Prion 5:49–51
Piro JR, Harris BT, Nishina K, Soto C, Morales R, Rees JR et al (2009) Prion protein glycosylation is not required for strain-specific neurotropism. J Virol 83:5321–5328
Polymenidou M, Stoeck K, Glatzel M, Vey M, Bellon A, Aguzzi A (2005) Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol 4:805–814
Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216:136–144
Prusiner SB (1997) Prion diseases and the BSE crisis. Science 278:245–251
Prusiner SB (1998a) Prions (Les Prix Nobel Lecture). In: Frängsmyr T (ed) Les Prix Nobel. Almqvist & Wiksell International, Stockholm, pp 268–323
Prusiner SB (1998b) Prions. Proc Natl Acad Sci USA 95:13363–13383
Prusiner SB (2001) Shattuck lecture—neurodegenerative diseases and prions. N Engl J Med 344:1516–1526
Prusiner SB (ed) (2004) Prion biology and diseases. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
Prusiner SB, Cochran SP, Groth DF, Downey DE, Bowman KA, Martinez HM (1982) Measurement of the scrapie agent using an incubation time interval assay. Ann Neurol 11:353–358
Prusiner SB, Scott M, Foster D, Pan K-M, Groth D, Mirenda C et al (1990) Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63:673–686
Prusiner SB, Scott MR, DeArmond SJ, Cohen FE (1998) Prion protein biology. Cell 93:337–348
Prusiner SB, Tremblay P, Safar J, Torchia M, DeArmond SJ (1999a) Bioassays of prions. In: Prusiner SB (ed) Prion biology and diseases. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 113–145
Prusiner SB, Scott MR, DeArmond SJ, Carlson G (1999b) Transmission and replication of prions. In: Prusiner SB (ed) Prion biology and diseases. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 147–190
Prusiner SB, Scott MR, DeArmond SJ, Carlson G (2004a) Transmission and replication of prions. In: Prusiner SB (ed) Prion biology and diseases. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 187–242
Prusiner SB, Legname G, DeArmond SJ, Cohen FE, Safar J, Riesner D et al (2004b) Some strategies and methods for the study of prions. In: Prusiner SB (ed) Prion biology and diseases. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 857–920
Puoti G, Giaccone G, Rossi G, Canciani B, Bugiani O, Tagliavini F (1999) Sporadic Creutzfeldt-Jakob disease: co-occurrence of different types of PrP(Sc) in the same brain. Neurology 53:2173–2176
Safar JG (2012) Molecular pathogenesis of sporadic prion diseases in man. Prion 6:108–115
Safar J, Roller PP, Gajdusek DC, Gibbs CJ Jr (1993) Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J Biol Chem 268:20276–20284
Safar J, Roller PP, Gajdusek DC, Gibbs CJ Jr (1994) Scrapie amyloid (prion) protein has the conformational characteristics of an aggregated molten globule folding intermediate. Biochemistry 33:8375–8383
Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M et al (1998) Eight prion strains have PrPSc molecules with different conformations. Nat Med 4:1157–1165
Safar J, Cohen FE, Prusiner SB (2000) Quantitative traits of prion strains are enciphered in the conformation of the prion protein. Arch Virol Suppl 2000:227–235
Safar JG, Scott M, Monaghan J, Deering C, Didorenko S, Vergara J et al (2002) Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat Biotechnol 20:1147–1150
Safar JG, Kellings K, Serban A, Groth D, Cleaver JE, Prusiner SB et al (2005a) Search for a prion-specific nucleic acid. J Virol 79:10796–10806
Safar JG, Geschwind MD, Deering C, Didorenko S, Sattavat M, Sanchez H et al (2005b) Diagnosis of human prion disease. Proc Natl Acad Sci USA 102:3501–3506
Safar JG, DeArmond SJ, Kociuba K, Deering C, Didorenko S, Bouzamondo-Bernstein E et al (2005c) Prion clearance in bigenic mice. J Gen Virol 86:2913–2923
Safar JG, Lessard P, Tamguney G, Freyman Y, Deering C, Letessier F et al (2008) Transmission and detection of prions in feces. J Infect Dis 198:81–89
Safar JG, Giles K, Lessard P, Letessier F, Patel S, Serban A (2011) et al. Conserved properties of human and bovine prion strains on transmission to guinea pigs, Lab Invest
Schoch G, Seeger H, Bogousslavsky J, Tolnay M, Janzer RC, Aguzzi A et al (2006) Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease. PLoS Med 3:e14
Scott M, Foster D, Mirenda C, Serban D, Coufal F, Wälchli M et al (1989) Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 59:847–857
Scott MR, Groth D, Tatzelt J, Torchia M, Tremblay P, DeArmond SJ et al (1997) Propagation of prion strains through specific conformers of the prion protein. J Virol 71:9032–9044
Scott MR, Will R, Ironside J, Nguyen H-OB, Tremblay P, DeArmond SJ et al (1999) Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci USA 96:15137–15142
Scott M, Peretz D, Ridley RM, Baker HF, DeArmond SJ, Prusiner SB (2004) Transgenetic investigations of the species barrier and prion strains. In: Prusiner SB (ed) Prion biology and diseases. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 435–482
Scott MR, Peretz D, Nguyen H-OB, DeArmond SJ, Prusiner SB (2005) Transmission barriers for bovine, ovine, and human prions in transgenic mice. J Virol 79:5259–5271
Shirley BA (ed) (1995) Protein stability and folding: theory and practice. Humana, Totowa, NJ
Stephenson DA, Chiotti K, Ebeling C, Groth D, DeArmond SJ, Prusiner SB et al (2000) Quantitative trait loci affecting prion incubation time in mice. Genomics 69:47–53
Tamguney G, Giles K, Glidden DV, Lessard P, Wille H, Tremblay P et al (2008) Genes contributing to prion pathogenesis. J Gen Virol 89:1777–1788
Tanaka M, Collins SR, Toyama BH, Weissman JS (2006) The physical basis of how prion conformations determine strain phenotypes. Nature 442:585–589
Taraboulos A, Rogers M, Borchelt DR, McKinley MP, Scott M, Serban D et al (1990) Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation. Proc Natl Acad Sci USA 87:8262–8266
Taraboulos A, Jendroska K, Serban D, Yang S-L, DeArmond SJ, Prusiner SB (1992) Regional mapping of prion proteins in brains. Proc Natl Acad Sci USA 89:7620–7624
Telling GC (2008) Transgenic mouse models of prion diseases. Methods Mol Biol 459:249–263
Telling GC, Scott M, Hsiao KK, Foster D, Yang S-L, Torchia M et al (1994) Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc Natl Acad Sci USA 91:9936–9940
Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R et al (1996) Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274:2079–2082
Tremblay P, Ball HL, Kaneko K, Groth D, Hegde RS, Cohen FE et al (2004) Mutant PrPSc conformers induced by a synthetic peptide and several prion strains. J Virol 78:2088–2099
Trevitt CR, Collinge J (2006) A systematic review of prion therapeutics in experimental models. Brain 129:2241–2265
Tuzi NL, Cancellotti E, Baybutt H, Blackford L, Bradford B, Plinston C et al (2008) Host PrP glycosylation: a major factor determining the outcome of prion infection. PLoS Biol 6:e100
Tzaban S, Friedlander G, Schonberger O, Horonchik L, Yedidia Y, Shaked G et al (2002) Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry 41:12868–12875
Uro-Coste E, Cassard H, Simon S, Lugan S, Bilheude JM, Perret-Liaudet A et al (2008) Beyond PrP9res) type 1/type 2 dichotomy in Creutzfeldt-Jakob disease. PLoS Pathog 4:e1000029
Wadsworth JDF, Hill AF, Joiner S, Jackson GS, Clarke AR, Collinge J (1999) Strain-specific prion-protein conformation determined by metal ions. Nat Cell Biol 1:55–59
Wang F, Wang X, Yuan CG, Ma J (2010) Generating a prion with bacterially expressed recombinant prion protein. Science 327:1132–1135
Watts JC, Westaway D (2007) The prion protein family: diversity, rivalry, and dysfunction. Biochim Biophys Acta 1772:654–672
Weissmann C (2004) The state of the prion. Nat Rev Microbiol 2:861–871
Zou WQ, Capellari S, Parchi P, Sy MS, Gambetti P, Chen SG (2003) Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease. J Biol Chem 278:40429–40436
Acknowledgments
This work was supported by grants from NIA (AG-14359), NINDS (NS074317), CDC (UR8/CCU515004), and the Charles S. Britton Fund.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Safar, J.G. (2013). Molecular Mechanisms Encoding Quantitative and Qualitative Traits of Prion Strains. In: Zou, WQ., Gambetti, P. (eds) Prions and Diseases. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5305-5_12
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5305-5_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5304-8
Online ISBN: 978-1-4614-5305-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)